Evidence map›Paper›PMID 33344657›Full record

ArticleJournal of immunology research2020

Anemoside B4 Protects against Acute Lung Injury by Attenuating Inflammation through Blocking NLRP3 Inflammasome Activation and TLR4 Dimerization.

Renyikun Yuan, Jia He, Liting Huang, Li-Jun Du, Hongwei Gao, Qiongming Xu, Shilin Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Anemoside B4, a new pyruvate carboxylase inhibitor, alleviates colitis by reprogramming macrophage function.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  18. Article
  19. Article
  20. Anemoside B4 inhibits SARS-CoV-2 replicationChinese herbal medicines · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Renyikun YuanCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.
Jia HeCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.
Liting HuangCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.
Li-Jun DuSchool of Life Sciences, Tsinghua University, Beijing 100084, China.
Hongwei GaoCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.ORCID https://orcid.org/0000-0001-9179-750X
Qiongming XuCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.ORCID https://orcid.org/0000-0001-6145-5509
Shilin YangCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.
Guangxi University · CNJiangxi University of Traditional Chinese Medicine · CNTsinghua University · CN

Funding

NIAAA NIH HHS L40 AA017002
6 · The paper itself

Abstract

Acute lung injury (ALI) is an acute inflammatory process in the lung parenchyma. Anemoside B4 (B4) was isolated from Pulsatilla, a plant-based drug against inflammation and commonly applied in traditional Chinese medicine. However, the anti-inflammatory effect and the mechanisms of B4 are not clear. In this study, we explored the potential mechanisms and anti-inflammatory activity of B4 both

Indexed as

Acute Lung InjuryAdenosine TriphosphateAnimalsCytokinesDisease Models, AnimalInflammasomesInflammation MediatorsMacrophagesMembrane Potential, MitochondrialMiceMitochondriaMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureNLR Family, Pyrin Domain-Containing 3 ProteinProtective AgentsAdenosine Triphosphateanemoside B4CytokinesInflammasomesInflammation MediatorsNLR Family, Pyrin Domain-Containing 3 ProteinProtective AgentsSaponinsToll-Like Receptor 4

Identifiers

PMID33344657
PMCPMC7732379
OpenAlexW3111663334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.